e-learning
resources
Stockholm 2002
Tuesday 17.09.2002
Epidemiology and clinical aspects of pneumonia in the ICU
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Efficacy and safety of systemic and prolonged low-dose thrombolysis in thromboembolic disease
P. A. Bulpa, E. Paternotte, G. Carbutti, J. C. Osselaer, M. Gonzalez, A. Dive, E. Installe, P. Evrard (Yvoir, Belgium)
Source:
Annual Congress 2002 - Epidemiology and clinical aspects of pneumonia in the ICU
Session:
Epidemiology and clinical aspects of pneumonia in the ICU
Session type:
Thematic Poster Session
Number:
3011
Disease area:
Pulmonary vascular diseases, Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. A. Bulpa, E. Paternotte, G. Carbutti, J. C. Osselaer, M. Gonzalez, A. Dive, E. Installe, P. Evrard (Yvoir, Belgium). Efficacy and safety of systemic and prolonged low-dose thrombolysis in thromboembolic disease. Eur Respir J 2002; 20: Suppl. 38, 3011
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Interventional treatment of pulmonary embolism: catheter-delivered local thrombolysis versus reduced-dose systemic thrombolysis
Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management
Year: 2021
Efficacy and safety of treatment with anticoagulants in patients with unprovoked venous thromboembolism in Korea
Source: International Congress 2016 – Acute pulmonary embolism
Year: 2016
Long-term safety and outcome of subcutaneous and intravenous treprostinil in patients with severe chronic pulmonary hypertension
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
Effectiveness of thrombolytic therapy in pulmonary thromboembolism
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007
Comparison of two regimens of oral anticoagulation in pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 632s
Year: 2006
Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism
Source: Eur Respir J 2007; 30: Suppl. 51, 544s
Year: 2007
Successful use of thrombolytic therapy in the management of acute proximal pulmonary embolism without significant haemodynamic compromise
Source: Eur Respir J 2005; 26: Suppl. 49, 272s
Year: 2005
Long-term safety and efficacy of imatinib in pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical treatment
Year: 2012
Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism
Source: Virtual Congress 2021 – Insights into pulmonary embolism
Year: 2021
Safety and efficacy of immunoadsorption as an add-on to medical treatment in patients with idiopathic pulmonary arterial hypertension
Source: International Congress 2017 – Outcomes and new treatment strategies in pulmonary hypertension
Year: 2017
Low-dose amiodarone therapy may be responsible of serious adverse pulmonary effects in patients without pre-existing lung disease
Source: Eur Respir J 2004; 24: Suppl. 48, 280s
Year: 2004
Should thrombolysis and sildenafil be given in the acute management of patients with large pulmonary embolism? An assessment of the short and long-term outcomes.
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
Successful use of sildenafil in the treatment of pulmonary hypertension in patients with severe non-operable chronic thromboembolic disease
Source: Annual Congress 2004 - Treatment of pulmonary hypertension
Year: 2004
Clinical efficacy of oral sildenafil therapy in the treatment of pulmonary hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 347s
Year: 2007
Efficacy of oral add-on therapy in patients with pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Risk factors for recurrences in patients with idiopathic pulmonary embolism after withdrawal of long-term anticoagulation
Source: Eur Respir J 2006; 28: Suppl. 50, 44s
Year: 2006
Risk assessment and prognosis in patients with pulmonary arterial hypertension receiving intravenous treprostinil
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
Combination therapy in severe pulmonary hypertension with bosentan and treprostinil: successful switch from subcutaneous to intravenous application
Source: Eur Respir J 2006; 28: Suppl. 50, 384s
Year: 2006
Safety of corticosteroid therapy in patients with pulmonary sarcoidosis
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017
Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment
Source: Eur Respir J 2016; 48: 1369-1376
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept